(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.13%) $0.928
(0.28%) $10.87
(0.01%) $0.792
(-0.03%) $92.55
Live Chart Being Loaded With Signals
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc)...
Stats | |
---|---|
Today's Volume | 28 500.00 |
Average Volume | 242 237 |
Market Cap | 10.61M |
EPS | $0 ( 2024-03-07 ) |
Next earnings date | ( $-0.200 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.260 |
ATR14 | $0.00900 (1.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-14 | Darvish Nissim | Buy | 20 572 | Option to Purchase American Depositary Shares |
2021-04-19 | Darvish Nissim | Buy | 11 884 | Option to Purchase American Depositary Shares |
2016-10-28 | Darvish Nissim | Buy | 10 123 | Option to Purchase American Depositary Shares |
2023-03-16 | Darvish Nissim | Buy | 6 857 | Option to Purchase American Depositary Shares |
2022-03-07 | Darvish Nissim | Buy | 6 820 | Option to Purchase American Depositary Shares |
INSIDER POWER |
---|
-57.19 |
Last 88 transactions |
Buy: 2 375 207 | Sell: 4 584 307 |
Volume Correlation
Anchiano Therapeutics Ltd Correlation
10 Most Positive Correlations | |
---|---|
SNGX | 0.895 |
LAWS | 0.894 |
NAKD | 0.892 |
DTSS | 0.891 |
CFMS | 0.886 |
IMV | 0.885 |
TNGX | 0.883 |
PIXY | 0.883 |
DBGI | 0.875 |
MRNA | 0.875 |
10 Most Negative Correlations | |
---|---|
SJ | -0.906 |
MLTX | -0.893 |
ACVA | -0.893 |
PEGA | -0.888 |
KIN | -0.886 |
TA | -0.885 |
NCAC | -0.883 |
CONX | -0.879 |
NEO | -0.877 |
MYNA | -0.876 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Anchiano Therapeutics Ltd Correlation - Currency/Commodity
Anchiano Therapeutics Ltd Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.06 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.270 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-18 938.00 (0.00 %) |
EPS: | $-0.340 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-15 818.00 (0.00 %) |
EPS: | $-0.720 |
Financial Reports:
No articles found.
Anchiano Therapeutics Ltd
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators